| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $1.83B | +10.3% |
| Cost of Revenue | $766.6M | +7.1% |
| Gross Profit | $1.06B | +12.7% |
| R&D Expense | $21.1M | +36.1% |
| SG&A Expense | $817.9M | +14.0% |
| Operating Income | $245.4M | +8.8% |
| Pre-tax Income | $232.8M | +3.1% |
| Income Tax | $57.2M | +2.0% |
| Net Income | $175.7M |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Accounts Receivable | $120.2M | +25.5% |
| Inventory | $310.1M | -8.1% |
| Current Assets | $826.8M | -9.6% |
| Total Assets | $1.29B | -0.9% |
| Current Liabilities | $379.5M | -4.7% |
| Long-term Debt | $78.0M | -5.1% |
| Total Liabilities | $546.0M | -4.8% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $261.4M | -8.6% |
| Capital Expenditures | $41.8M | -17.4% |
| Investing Cash Flow | -$131.4M | -80.5% |
| Financing Cash Flow | -$209.2M | -1438.8% |
| Free Cash Flow | $219.6M | -6.7% |
| +3.4% |
| EPS (Basic) | $2.07 | +5.6% |
| EPS (Diluted) | $2.05 | +5.7% |
| Stockholders' Equity |
| $740.1M |
| +2.3% |